Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

Background and Aim. EGFR is commonly expressed in cancers of the head and neck (H and N), and anti-EGFR agents have demonstrated improvements in outcomes (TTP and OS). The aim of this study was to determine EGFR gene status in H and N cancer patients treated with gefitinib and to correlate mutationa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Murray, Samuel, Bobos, Mattheos, Angouridakis, Nikolaos, Nikolaou, Angelos, Linardou, Helena, Razis, Evangelia, Fountzilas, George
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2010
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3022192/
https://ncbi.nlm.nih.gov/pubmed/21274259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/709678
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak